Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Correction: Highly secreted tryptophanyl tRNA synthetase 1 as a potential theranostic target for hypercytokinemic severe sepsis.

Autor: Kim YT; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea., Huh JW; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Choi YH; R&D Center, MirimGENE, Incheon, Republic of Korea., Yoon HK; R&D Center, MirimGENE, Incheon, Republic of Korea., Nguyen TT; R&D Center, MirimGENE, Incheon, Republic of Korea., Chun E; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea., Jeong G; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea., Park S; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea., Ahn S; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Lee WK; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea., Noh YW; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea., Lee KS; Non-Clinical Evaluation Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea., Ahn HS; Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea., Lee C; Chemical & Biological Integrative Research Center, Korea Institute of Science and Technology, Seoul, Republic of Korea., Lee SM; Department of Internal Medicine, Gil Medical Center, College of Medicine, Gachon University, Incheon, Republic of Korea., Kim KS; Department of Emergency Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Suh GJ; Department of Emergency Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea., Jeon K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Kim S; Medicinal Bioconvergence Research Center, Institute for Artificial Intelligence and Biomedical Research, The interdisciplinary graduate program in integrative biotechnology, College of Pharmacy & College of Medicine, Gangnam Severance Hospital, Yonsei University, Incheon, Republic of Korea., Jin M; Department of Health Sciences and Technology, GAIHST, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; R&D Center, MirimGENE, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.; Department of Microbiology, College of Medicine, Gachon University, Incheon, Republic of Korea. mirimj@gachon.ac.kr.

Publikováno v: EMBO molecular medicine [EMBO Mol Med] 2024 Mar; Vol. 16 (3), pp. 665.